4//SEC Filing
ENZO BIOCHEM INC 4
Accession 0000930413-07-006667
CIK 0000316253operating
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 9:53 PM ET
Size
7.7 KB
Accession
0000930413-07-006667
Insider Transaction Report
Form 4
GOLDBERG DAVID C
VP, Corporate Development
Transactions
- Conversion
Employee Stock Option
2007-08-09−3,191→ 54,719 totalExercise: $11.65From: 1997-08-27Exp: 2007-08-27→ Common Stock, par value $0.01 per share (3,191 underlying) - Conversion
Common Stock, par value $0.01 per share
2007-08-09+3,191→ 99,654 total
Footnotes (2)
- [F1]The Reporting Person exercised a stock option to purchase 3,191 shares of Common Stock and paid the exercise price thereof by the surrender of 2,082 shares of Common Stock, for a net gain in outstanding shares of Common Stock of 1,109 shares. The stated exercise price of the stock options was $11.655.
- [F2]As of the date hereof, the Reporting Person directly beneficially owned 40,854 shares of Common Stock, 979 shares indirectly beneficially owned through the UGMA accounts of the Reporting Person's children, 3,102 shares of Common Stock in Enzo Biochem's 401(K) Plan and 54,719 options to purchase Common Stock, par value $0.01 per share, which are currently exercisable.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000316253
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 9:53 PM ET
- Size
- 7.7 KB